The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence
Mykhailo Buchynskyi(I.Horbachevsky Ternopil National Medical University), Oleksandr Kamyshnyi(I.Horbachevsky Ternopil National Medical University), Valentyn Oksenych(University of Bergen), Iryna Kamyshna(I.Horbachevsky Ternopil National Medical University), N. H. Zavidniuk(I.Horbachevsky Ternopil National Medical University)
Cited by 20
Related Papers
Effects of metformin on the gut microbiota: A systematic review
|Molecular Metabolism|2023|91
The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin
|Biomedicine & Pharmacotherapy|2023|70
Modulating Nitric Oxide: Implications for Cytotoxicity and Cytoprotection
|Antioxidants|2024|64
Diabetes and Osteoarthritis: Exploring the Interactions and Therapeutic Implications of Insulin, Metformin, and GLP-1-Based Interventions
|Biomedicines|2024|51
Current treatment options for leptospirosis: a mini-review
|Frontiers in Microbiology|2024|48